Music |
Video |
Movies |
Chart |
Show |
CRSP, Vertex, Viacyte and Genprex tackle Diabetes (T1D u0026 T2D) with novel approaches. (ShareTreck) View | |
CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes (HealthWealth) View | |
Vertex went all in on Diabetes and is now starting to see success with VX-880. (ShareTreck) View | |
Vertex u0026 CRISPR Therapeutics collaborate for T1D therapies using CRISPR/Cas9 technology. Good/bad (ShareTreck) View | |
Genprex (Alliance for Regenerative Medicine) View | |
GSK-126 | Diabetic Treatment | RESTORES Insulin Producing Cells (Vithal Panday, M.D.) View | |
CRISPR Therapeutics: 5 reasons why I have high conviction to invest in CRSP stock (ShareTreck) View | |
Genprex (GNPX) NobleCon18 Presentation Replay (channelchek) View | |
CRSP Stock emerges stronger - great progress in Exa-Cel u0026 VCTX-210. Will stock go out of our reach (ShareTreck) View | |
() View |